Dr. 박상윤
Dr. Park Sang Yun
학력
1973-03 1979-02 서울대학교 의과대학 의학과 대졸(의대)
1981-03 1983-02 서울대학교 의과대학 의학과 대학원졸(석사)
1989-09 1991-08 고려대학교 의과대학교 의학과 대학원졸(박사)
경력
1979-03 1980-02 서울대학교병원 인턴
1980-03 1983-02 서울대학교병원 레지던트
1986-04 1987-02 차병원 과장
1987-04 2000-09 원자력병원 산부인과 과장
1997-07 1997-07 Washington Cancer Institute, USA Visiting doctor
1997-08 1997-08 Mainz University, Germany Visiting doctor
2000-10 2009-01 국립암센터 자궁암센터 센터장
2000-10 현재 국립암센터 자궁암센터 전문의
2001-05 2007-11 국립암센터 자궁암연구과 과장, 책임연구원
2003-04 2007-04 국립암센터 호발암연구과 부장
2007-04 2007-11 국립암센터 이행성임상연구부 부장
2007-06 2012-01 국립암센터 자궁암연구과 수석연구원
2007-12 2009-12 국립암센터 자궁암연구과 과장, 수석연구원
2011-08 2014-08 국립암센터 자궁암센터 센터장
2012-01 2017-02 국립암센터 부인암연구과 수석연구원
2017-03 2018-06 국립암센터 호발암연구과 수석연구원
2019-07 현재 국립암센터 자궁난소암센터 초빙의
논문
2019 Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study: . : ()
2019 SCI Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer: THE NEW ENGLAND JOURNAL OF MEDICINE. 20:1929~1939 (70.67)
2019 SCI-E A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D: JOURNAL OF GYNECOLOGIC ONCOLOGY. Online:Published (2.914)
2019 SCI Type-Specific Viral Load and Physical State of HPV Type 16, 18, and 58 as Diagnostic Biomarkers for High-Grade Squamous Intraepithelial Lesions or Cervical Cancer: CANCER RESEARCH AND TREATMENT. Online:Published (3.363)
2019 SCI-E Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial: THE LANCET ONCOLOGY. 20(6):862~876 (35.386)
2019 SCI-E Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. Online:Published (2.183)
2019 SCI-E Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study: JOURNAL OF GYNECOLOGIC ONCOLOGY. 30(3):e44~e44 (2.914)
2019 SCI-E Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708): BMC CANCER. 19(1):341~341 (2.933)
2019 SCI-E Delayed IL-21 treatment preferentially expands peptide-specific CD8+ T cells by reducing bystander activation of T cells: IMMUNOTHERAPY. 11(6):497~513 (3.028)
2019 SCI Suprarenal lymph node dissection by the Kocher maneuver in the surgical management of ovarian cancer: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 29(3):647~648 (1.746)
2019 SCI-E Peritoneal cancer index in ovarian cancer: JOURNAL OF GYNECOLOGIC ONCOLOGY. 30(1):e14~e14 (2.914)
2019 SCI Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041): GYNECOLOGIC ONCOLOGY. 152(1):61~67 (4.54)
2019 SCI-E Functional loss in daily activity in ovarian cancer patients undergoing chemotherapy: Archives of Gynecology and Obstetrics. Online:Published (2.236)
2018 SCI-E Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: CANCER RESEARCH AND TREATMENT. 51(1):112~118 (3.23)
2018 SCI-E Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers: CANCER RESEARCH AND TREATMENT. 51(1):280~288 (3.23)
2018 SCI Prognostic Value of Pathologic Chemotherapy Response Score in Patients With Ovarian Cancer After Neoadjuvant Chemotherapy: International journal of gynecological cancer. 28(9):1676~1682 (2.192)
2018 SCI Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial: Gynecologic oncology. 151(1):39~45 (4.54)
2018 SCI-E Comparison of gynecologic cancer risk factors, incidence and mortality trends between South Korea and Israel, 1999-2013: Japanese journal of clinical oncology. 48(10):884~891 (2.37)
2018 SCI Treatment Results and Prognostic Factors of Brain Metastases From Ovarian Cancer: International journal of gynecological cancer. 28(8):1631~1638 (2.192)
2018 SCI-E Changes in ovarian cancer survival during the 20 years before the era of targeted therapy: BMC Cancer. 18(1):601~601 (3.288)
2018 SCI-E Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons: World journal of surgical oncology. 16(1):92~92 (1.792)
2018 SCI Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae: Journal of cancer research and clinical oncology. 144(5):845~854 (3.282)
2017 SCI-E Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer: Journal of Gynecologic Oncology. 28(4):e48~e48 (3.14)
2017 SCI General health status of long-term cervical cancer survivors after radiotherapy: Strahlentherapie Und Onkologie. 193(7):543~551 (2.735)
2017 SCI Comparison of the Abbott RealTime High Risk HPV test and the Roche cobas 4800 HPV test using urine samples: Journal of Virological Methods. 243:74~79 (1.693)
2016 SCI-E Development of the short version of the Gynecologic Cancer Lymphedema Questionnaire: GCLQ-7: Journal of Gynecologic Oncology. 28(2):e9~e9 (2.522)
2016 SCI-E Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer: Brachytherapy. 16(1):116~125 (2.088)
2016 SCI Magnetic resonance image-guided brachytherapy for cervical cancer : Prognostic factors for survival.: Strahlentherapie und Onkologie. 192(12):922~930 (2.898)
2016 SCI Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K).: J Korean Med Sci. 31(12):1969~1975 (1.256)
2016 SCI-E Comparison of Quality of Life and Sexuality between Cervical Cancer Survivors and Healthy Women. Cancer Res Treat: Cancer research and treatment. 48(4):1321~1329 (4.245)
2016 SCI Knowledge of HPV and Surgery among Women Who Underwent Cervical Conization: A Korean Multi-Center Study: Yonsei Medical Journal. 57(5):1222~1229 (1.154)
2016 SCI Prophylactic irradiation of para-aortic lymph nodes for patients with locally advanced cervical cancers with and without high CA9 expression (KROG 07-01): A randomized, open-label, multicenter, phase 2 trial: Radiotherapy and Oncology. 120(3):383~389 (4.817)
2016 SCI-E A Rare Case of Phyllodes Tumor Metastasis to the Stomach Presenting as Anemia: Cancer research and treatment. Online:Published (4.245)
2016 SCI-E Health Behaviors and Associated Sociodemographic Factors in Cervical Cancer Survivors Compared with Matched Non-Cancer Controls.: PLoS One. 11(8):e0160682~e0160682 (3.057)
2016 SCI Comparison of DRY and WET vaginal swabs with cervical specimens in Roche Cobas 4800 HPV and Abbott RealTime High Risk HPV tests: Journal of Clinical Virology. 79:80~84 (2.647)
2016 SCI Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer: International Journal of Gynecological Cancer. 26(4):737~742 (2.116)
2016 SCI Improved Postoperative Pain Control for Cytoreductive Surgery in Women With Ovarian Cancer Using Patient-Controlled Epidural Analgesia.: International Journal of Gynecologic Cancer. 26:588~593 (2.116)
2016 SCI BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study: Gynecologic Oncology. :443~449 ()
2015 SCI Preoperative prediction of cardiophrenic lymph node metastasis in advanced ovarian cancer using computed tomography: Annals of surgical oncology. 23(4):1302~1308 (3.93)
2015 SCI-E Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer: Cancer research and treatment. 48(2):641~649 (3.318)
2015 SCI-E Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999-2012: Journal of Gynecologic Oncology. 27(1):e5~e5 (2.494)
2015 SCI Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer: Annals of surgical oncology. 23(1):186~195 (3.93)
2015 SCI Comparison of Lower Extremity Edema in Locally Advanced Cervical Cancer: Pretreatment Laparoscopic Surgical Staging with Tailored Radiotherapy Versus Primary Radiotherapy.: Annals of surgical oncology. 23(1):203~210 (3.93)
2015 SCI Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.: Journal of Cancer Research and Clinical Oncology. 142(1):333~340 (3.081)
2015 SCI Health-Related Quality of Life and Sociodemographic Characteristics as Prognostic Indicators of Long-term Survival in Disease-Free Cervical Cancer Survivors: 2016 IGCS and ESGO. :743~749 ()
2015 SCI Pazopanib Maintenance Therapy in East Asian Women With Advanced Epithelial Ovarian Cancer: International journal of gynecological cancer. Online:Published (1.958)
2015 SCI Of the 61 patients, 67.2% were diagnosed at early stage (I to IIA) with a median age of 49 years. Of those, 78% underwent surgery and 75.6% received postoperative adjuvant treatment. For patients diagnosed at advanced stage, 60.0% received chemotherapy only and 25.0% received concurrent chemoradiation therapy. In the univariate analysis, advanced stage (77 vs. 40 months, P=0.013), tumor size ≥2 cm (133 vs. 47 months, P=0.002) and mixed tumor (101 vs. 34 months, P=0.004) were shown to be poor prognostic factors. In the multivariate analysis, tumor stage, tumor size and tumor homology were shown to be independent prognostic factors for overall survival. Of the total, 39.3% of the patients experienced recurrence, and 54.1% of the patients had metastasis. Of the patients diagnosed at early stage, 51.2% experienced recurrence.: Obstetrics & Gynecology Science. :116~122 ()
2015 SCI Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2: Annals of clinical biochemistry. Online:Published (2.335)
2015 SCI Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection: European journal of obstetrics, gynecology, and reproductive biology. 192:31~36 (1.695)
2015 SCI-E The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea: Clinical microbiology and infection. 21(7):1~9 (5.768)
2015 SCI-E Multi-dimensional TOF-SIMS analysis for effective profiling of disease-related ions from the tissue surface.: Scientific reports.. 5:11077~11085 (5.578)
2015 SCI The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study: Gynecologic oncology. 137(3):412~417 (3.774)
2015 SCI Alcohol consumption and persistent infection of high-risk human papillomavirus: Epidemiology and Infection. 143:1442~1450 (2.535)
2015 SCI-E Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women: Journal of gynecologic oncology. 26(2):148~154 (2.494)
2015 SCI-E Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial.: Journal of gynecologic oncology. 26(2):90~99 (2.494)
2015 SCI-E Survival outcome in endometrial cancer patients according to hereditary predisposition: Taiwanese journal of obstetrics & gynecology. 54(1):24~28 (0.988)
2015 SCI-E Ligation of uterine vessels in total laparoscopic hysterectomy using Hem-o-lok clips.: Taiwanese journal of obstetrics & gynecology. 54(1):8~12 (0.988)
2015 SCI Benefit of Negative Pressure Drain Within Surgical Wound After Cytoreductive Surgery for Ovarian Cancer: International jouranl of gynecological cancer. 25(1):145~151 (1.958)
2015 SCI-E Asian Society of Gynecologic Oncology International Workshop 2014: Journal of gynecologic oncology. 26(1):68~74 (2.494)
2014 SCI Low Expression of miR-449 in Gynecologic Clear Cell Carcinoma: International journal of gynecological cancer. 24(9):1558~1563 (1.949)
2014 SCI-E Completeness of pedigree and family cancer history for ovarian cancer patients: Journal of gynecologic oncology. 25(4):342~348 (1.6)
2014 SCI Lymph Node Status Did Not Significantly Improve the Predictability of Survival in Patients With Clinically Early-Stage Endometrial Cancer: International journal of gynecological cancer. 24(8):1449~1454 (1.949)
2014 SCI Development and validation of the korean version of the female sexual function index-6 (FSFI-6K): Yonsei medical journal. 55(5):1442~1446 (1.263)
2014 SCI-E Synergistic Effect of Viral Load and Alcohol Consumption on the Risk of Persistent High-Risk Human Papillomavirus Infection: PLoS One. 9(8):e104374~e104374 (3.534)
2014 SCI A nomogram predicting the risks of distant metastasis following postoperative radiotherapy for uterine cervical carcinoma: a Korean radiation oncology group study (KROG 12-08): Radiotherapy and oncology. 111(3):437~441 (4.857)
2014 SCI Development and Evaluation of Korean Version of Quality of Sexual Function (QSF-K) in Healthy Korean Women: Journal of Korean Medical Science. 29(6):758~763 (1.253)
2014 SCI-E The association of self-leadership, health behaviors, and posttraumatic growth with health-related quality of life in patients with cancer: PSYCHO-ONCOLOGY. 3582:3582~3582 (4.044)
2014 SCI Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors: Gynecologic Oncology. 133(1):111~116 (3.687)
2014 SCI High-mobility group box 1 (HMGB1) protein regulates tumor-associated cell migration through the interaction with BTB domain: Cellular Signalling. 26(4):777~783 (4.471)
2014 SCI-E Lower extremity edema in patients with early ovarian cancer: Journal of ovarian research. 7(1):28~28 (2.03)
2014 SCI-E Prognostic implication of retrocrural lymph node involvement revealed by (18)F-FDG PET/CT in patients with uterine cervical cancer: Nuclear medicine communications. 35(3):268~275 (1.371)
2014 SCI A Web-Based Nomogram Predicting Para-aortic Nodal Metastasis in Incompletely Staged Patients With Endometrial Cancer: A Korean Multicenter Study: International journal of gynecological cancer. 24(3):513~519 (1.949)
2014 SCI Prognostic factors in women with synchronous endometrial and ovarian cancers: International journal of gynecological cancer. 24(3):520~527 (1.949)
2014 SCI Application of a subcutaneous negative pressure drain without subcutaneous suture: impact on wound healing in gynecologic surgery: European journal of obstetrics & gynecology and reproductive biology. 173:94~100 (1.627)
2014 SCI Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study: British journal of cancer. 110(2):278~285 (4.817)
2013 SCI-E Dosimetric Evaluation of Magnetic Resonance Imaging-based Intracavitary Brachytherapy for Cervical Cancer: Technology in Cancer Research and Treatment. 13(3):243~251 (1.886)
2013 SCI-E Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.: Journal of Gynecologic Oncology. 24(4):298~302 (1.73)
2013 SCI The correlates of unemployment and its association with quality of life in cervical cancer survivors: Journal of Gynecologic Oncology. 24(4):367~375 (1.73)
2013 SCI-E Employment Status and Work-Related Difficulties among Family Members of Terminally Ill Patients Compared with the General Population: Asian Pacific Journal of Cancer Prevention. 14(1):373~380 (1.271)
2013 SCI-E Trends in the Incidence of In Situ and Invasive Cervical Cancer by Age Group and Histological Type in Korea from 1993 to 2009: PLoS One. 8(8):e72012~e72012 (3.73)
2013 SCI BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents: International journal of biochemistry and cell biology. 45(7):1236~1245 (4.152)
2013 SCI The size of the metastatic lymph node is an independent prognostic factor for the patients with cervical cancer treated by definitive radiotherapy: Radiotherapy and Oncology. 1081(1):168~173 (4.52)
2013 SCI Transabdominal cardiophrenic lymph node dissection (CPLND) via incised diaphragm replace conventional video-assisted thoracic surgery for cytoreductive surgery in advanced ovarian cancer: Gynecologic Oncology. 129(2):341~345 (3.929)
2013 SCI-E High Control Rate for Lymph Nodes in Cervical Cancer Treated with High-dose Radiotherapy using Helical Tomotherapy: Technology in Cancer Research and Treatment. 12(1):45~51 (1.943)
2013 SCI-E Brain metastasis in patients with uterine cervical cancer: Journal of Obstetrics and Gynaecology Research. 39(1):287~291 (0.841)
2012 SCI-E Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.: Archives of gynecology and obstetrics.. 286(6):1529~1535 (1.277)
2012 SCI-E Urologic complications of laparoscopic radical hysterectomy and lymphadenectomy: International urogynecology journal. 23(11):1605~1611 (1.832)
2012 SCI-E Efficacy of systematic pelvic lymphadenectomy in patients with non-endometrioid endometrial cancers: A retrospective, multicenter study in Korea: The journal of obstetrics and gynaecology research.. 38(11):1321~1327 (0.942)
2012 SCI-E Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea: Journal of Gynecology Oncology. 23(4):242~250 (1.489)
2012 SCI sMEK1 enhances gemcitabine anti-cancer activity through inhibition of phosphorylation of Akt/mTOR: Apoptosis. 17(10):1095~1103 (4.788)
2012 SCI Learning curve analysis of laparoscopic radical hysterectomy and lymph node dissection in early cervical cancer.: European journal of obstetrics, gynecology, and reproductive biology.. 163(2):219~223 (1.974)
2012 SCI Risk Assessment Tool for Distant Recurrence After Platinum-Based Concurrent Chemoradiation in Patients With Locally Advanced Cervical Cancer: A Korean Gynecologic Oncology Group Study.: Journal of Clinical Oncology. 30(19):2369~2374 (18.372)
2012 SCI DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis: Cellular Signalling. 24(7):1471~1477 (4.058)
2012 기타 Intraoperative image-guided surgery for ovarian cancer: Quantitative imaging in medicine and surgery. 3:114~117 (0)
2012 SCI Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy.: Fertility and sterility.. 97(6):1387~1393 (3.775)
2012 SCI Safe Criteria for Less Radical Trachelectomy in Patients with Early-Stage Cervical Cancer: A Multicenter Clinicopathologic Study.: Annals of Surgical Oncology. 19(6):1973~1979 (4.166)
2012 SCI Standardization of cytoreductive surgery is a precondition for clinical trials of ovarian cancer including cytoreductive surgery and/or neoadjuvant chemotherapy: Gynecologic oncology. 125(2):510~510 (3.888)
2012 SCI Serum HE4 Level is an Independent Prognostic Factor in Epithelial Ovarian Cancer: Annals of Surgical Oncology. 19(5):1707~1712 (4.166)
2012 SCI Web-Based Tailored Education Program for Disease-Free Cancer Survivors With Cancer-Related Fatigue: A Randomized Controlled Trial: Journal of Clinical Oncology. 30(12):1296~1303 (18.372)
2012 SCI Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study: Journal of Clinical Oncology. 30(12):1329~1334 (18.372)
2012 SCI-E How to make the best strategy to manage thromboembolism in ovarian cancer?: Journal of gynecologic oncology. 23(2):78~79 (1.489)
2012 SCI Correlation Between Body Mass Index and Prevalence of Hereditary Nonpolyposis Colorectal Cancer in Korean Patients With Endometrial Cancer: International Journal of Gynecological Cancer. 22(2):267~272 (1.646)
2012 SCI-E The comparison of clinicopathological characteristics in primary malignant mixed m?llerian tumour with epithelial endometrial carcinoma: The Australian & New Zealand journal of obstetrics & gynaecology. 52(1):44~48 (1.237)
2012 SCI-E Hereditary portion as an initial genetic approach in gynecologic cancer: synchronous tumor of ovary and endometrium: Journal of Gynecologic Oncology. 23(1):72~73 (1.489)
2012 SCI Management of the Elderly Patient With Gynecologic Cancer: Report of the 2011 Workshop in Geriatric Gynecologic Oncology.: International Journal of Gynecological Cancer. 22(1):161~169 (1.646)
2012 SCI Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2: Cellular Signalling. 24(1):131~139 (4.058)
2011 SCI-E Outcomes and toxicities for the treatment of stage IVB cervical cancer: Archives of gynecology and obstetrics. 285(6):1685~1693 (1.277)
2011 SCI Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer.: Anticancer drugs. Online:Published (2.376)
2011 SCI Is Neo-adjuvant Chemotherapy a "Waiver" of Extensive Upper Abdominal Surgery in Advanced Epithelial Ovarian Cancer?: Annals of Surgical Oncology. 18(13):3824~3827 (4.182)
2011 SCI Alteration in lipid and protein profiles of ovarian cancer: similarity to breast cancer.: International Journal of Gynecological Cancer. 21(9):1566~1572 (1.558)
2011 SCI Sentinel lymph node biopsy in endometrial cancer: Meta-analysis of 26 studies.: Gynecologic oncology. 123(3):522~527 (3.76)
2011 SCI Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer: International Journal of Cancer. 129(4):896~902 (4.926)
2011 SCI Impact of Awareness of Terminal Illness and Use of Palliative Care or Intensive Care Unit on the Survival of Terminally Ill Patients With Cancer: Prospective Cohort Study.: Journal of clinical oncology. 29(18):2474~2480 (18.97)
2011 SCI Extended Cytoreduction of Tumor at the Porta Hepatis by an Interdisciplinary Team Approach in Patients with Epithelial Ovarian Cancer: Gynecologic Oncology. 121(2):253~257 (3.76)
2011 SCI Efficacy of Para-Aortic Lymphadenectomy in Early-Stage Endometrioid Uterine Corpus Cancer.: Annals of Surgical Oncology. 18(5):1425~1430 (4.182)
2011 SCI-E Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix: JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 41(5):624~629 (1.856)
2011 SCI Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels.: GYNECOLOGIC AND OBSTETRIC INVESTIGATION. 72(1):50~54 (1.031)
2011 SCI Pelvic Lymph Node Status Assessed by 18f-Fluorodeoxyglucose Positron Emission Tomography Predicts Low-Risk Group for Distant Recurrence in Locally Advanced Cervical Cancer: A Prospective Study.: International journal of radiation oncology, biology, physics. 79(3):788~793 (4.503)
2011 SCI Embryonic-Natural Orifice Transumbilical Endoscopic Surgery (E-NOTES) for Myomectomy with Traction of Multi-directional Sutures: A New Surgical Approach.: Journal of Laparoendoscopic & Advanced Surgical Techniques. 21(1):35~37 (1.198)
2011 SCI-E Region-based Diagnostic Performance of Multi-detector CT for Detecting Peritoneal Seeding in Ovarian Cancer Patients: Archives of Gynecology and Obstetrics. 283(2):353~360 (1.072)
2011 SCI Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53: FEBS Letters. 585:29~35 (3.601)
2011 SCI Interaction between preoperative CA-125 level and survival benefit of neoadjuvant chemotherapy in advanced epithelial ovarian cancer: Gynecologic Oncology. 120(1):18~22 (3.76)
2010 SCI-E Hereditary Non-polyposis Colorectal Cancer/Lynch Syndrome in Korean Patients with Endometrial Cancer: Japanese Journal of Clinical Oncology. 40(12):1121~1127 (1.498)
2010 SCI Identification of a patient group at low risk for parametrial invasion in early-stage cervical cancer.: Gynecologic oncology. 119(3):426~430 (3.733)
2010 SCI Preoperative prediction model of lymph node metastasis in endometrial cancer.: International Journal of Gynecological Cancer. 20(8):1350~1355 (2.179)
2010 SCI Role of systematic lymphadenectomy and adjuvant radiation in early-stage endometrioid uterine cancer.: Annals of Surgical Oncology. 17(11):2951~2957 (4.13)
2010 SCI Ovarian Clear Cell Carcinoma: High Risk of Venous Thromboembolism: Gynecologic Oncology. 118:317~318 (3.733)
2010 SCI-E Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy.: Radiation Oncology. 5:78~78 (2.529)
2010 SCI Feasibility and Safety of Extensive Upper Abdominal Surgery in Elderly Patients with Advanced Epithelial Ovarian Cancer: Journal of Korean Medical Science. 25(7):1034~1040 (0.843)
2010 SCI Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer: Onkologies. 33(6):324~330 (1.234)
2010 SCI Experiences and Attitudes of Patients With Terminal Cancer and Their Family Caregivers Toward the Disclosure of Terminal Illness.: Journal of clinical oncology. 28(11):1950~1957 (17.793)
2010 SCI-E Lower urinary tract injuries diagnosed after hysterectomy: Seven-year experience at a cancer hospital: The Journal Of Obstetrics and Gynaecology Research. 36:318~325 (0.777)
2010 SCI Pathologic diagnosis and resection of suspicious thoracic metastases in patients withcervical cancer through thoracotomy or video-assisted thoracic surgery: Gynecologic Oncology. 116(3):478~482 (3.733)
2010 SCI Diagnostic Value of 18F-FDG PET for Evaluation of Paraaortic Nodal Metastasis in Patients with Cervical Carcinoma: A Metaanalysis.: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 51(3):360~367 (6.424)
2010 SCI Clinical Presentation of Endometrioid Epithelial Ovarian Cancer with Concurrent Endometriosis: A Multicenter Retrospective Study: Cancer Epidemiology Biomarker & Prevention. 19(2):398~404 (4.31)
2010 SCI Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer: European Radiology. 20:100~107 (3.589)
2010 SCI Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: A meta-analysis.: Journal of Surgical Oncology. 101(1):13~17 (2.502)
2009 SCI-E The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer: European Journal of Radiology. 75(2):230~235 (2.645)
2009 SCI-E Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma: Archives of Gynecology and Obstetrics. 281(2):329~334 (0.912)
2009 SCI-E Appendectomy in Retrograde Order for Complete Removal of Endometriosis: Gynecological Endocrinology. 25(12):844~847 (1.359)
2009 SCI Embryonic natural orifice transumbilical endoscopic surgery (E-NOTES) for adnexal tumors: Surgical Endoscopy. 23(11):2445~2449 (3.231)
2009 SCI Promising minimal surgical approach for gynecologic disease: Gynecologic Oncology. 115(2):320~321 (2.919)
2009 SCI BRCA1 and BRCA2 Germline Mutations in Korean Ovarian Cancer Patients: Journal of Cancer Research and Clinical Oncology. 153(11):1593~1599 (2.217)
2009 SCI Low initial HPV viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.: Journal of Clinical Oncology. 92:138~141 (17.157)
2009 SCI Cervical cancer patient information-seeking behaviors, information needs, and information sources in South Korea: Supportive Care in Cancer. 17:1277~1283 (2.422)
2009 SCI Laparoscopy-assisted ICR tandem placement for patients with cervical cancer: International Journal of Gynecological Cancer. 19:1125~1130 (1.932)
2009 SCI Natural history of persistent high-risk human papillomavirus infections in Korean women: Gynecologic Oncology. 115(1):75~80 (2.919)
2009 SCI Nadir CA-125 level is an independent prognostic factor in advanced epithelial ovarian cancer: Journal of Surgical Oncology. 100(3):244~247 (2.478)
2009 SCI-E Different role of secondary cytoreductive surgery by surgeon’s experience and hospital facility: Journal of Gynecologic Oncology. 20:199~199 ()
2009 SCI Total colectomy as part of primary cytoreductive surgery in advanced mullerian cancer: Gynecologic Oncology. 114(2):183~187 (2.919)
2009 SCI Pathological Diagnosis and Cytoreduction of Cardiophrenic Lymph Node and Pleural Metastasis in Ovarian Cancer Patients Using Video-Assisted Thoracic Surgery: Annals of Surgical Oncology. 16(7):1990~1996 (3.898)
2009 SCI-E Clinical manifestations in patients with ovarian clear cell carcinoma with or without co-existing endometriosis: Gynecological Endocrinology. 25(7):435~440 (1.359)
2009 SCI-E Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer: Journal of Gynecologic Oncology. 20(2):101~106 ()
2009 SCI-E Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia: Journal of Gynecologic Oncology. 20(2):86~90 (0)
2009 SCI Enterovascular Fistula in a Patient with Squamous Cell Carcinoma Arising in a Cystic Teratoma: Southern Medical Journal. 102:553~554 (1.058)
2009 SCI Metastasis at the site of venous needle punctures in patients with advanced cervical cancer: European Journal of Obstetrics & Gynecology and Reproductive Biology. Online:Published (1.565)
2009 SCI Hyperthermic Intraperitoneal Chemotherapy Following Extensive Cytoreductive Surgery in Patients with Primary Advanced Epithelial Ovarian Cancer: Interim Analysis of a Phase II Study: Annals of Surgical Oncology. 16(4):993~1000 (3.898)
2009 SCI Endometrioid Adenocarcinoma in Urethrovaginal Septum: A Diagnostic Pitfall: Journal of Korean Medical Science. 24(1):162~165 (0.843)
2009 SCI Cervical cancer patient information-seeking behaviors, information needs, and information sources in South Korea: Supportive Care in Cancer. 17:1277~1283 (2.422)
2008 SCI-E Primary yolk sac tumor of the omentum: a case report and review of the literature: Archives of Gynecology and Obstetrics. 279(2):189~192 (0.666)
2008 SCI The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer.: Gynecologic Oncology. 112(1):28~34 (2.614)
2008 SCI Calpain 6 supports tumorigenesis by inhibiting apoptosis and facilitating angiogenesis: Cancer Letters. 271:306~313 (3.398)
2008 SCI Insulin-like growth factor binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis: Carcinogenesis. 29:2106~2111 (5.406)
2008 SCI Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety: International Journal of Gynecological Cancer. Online:Published (1.425)
2008 SCI-E Unusual 2-[18F]-fluoro-2-deoxy-D: -glucose accumulation induced by postoperative intestinocutaneous fistula in the patient with uterine cervical cancer and SLE.: Archives of Gynecology and Obstetrics. Online:Published (0.666)
2008 SCI Does the use of a uterine manipulator with an intrauterine balloon in total laparoscopic hysterectomy facilitate tumor cell spillage into the peritoneal cavity in patients with endometrial cancer?: International Journal of Gynecological Cancer. 18:1145~1149 (1.425)
2008 SCI Comorbidity in disease-free survivors of cervical cancer compared with the general female population: Oncology. 74:207~215 (2.444)
2008 SCI The validity of tumour diameter assessed by magnetic resonance imaging and gross specimen with regard to tumour volume in cervical cancer patients: European Journal of Cancer. 44:1524~1528 (4.454)
2008 SCI Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis: Cardiovascular Research. 79:150~160 (6.127)
2008 SCI Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer: Gynecologic Oncology. 109:359~363 (2.614)
2008 SCI Outcomes of colorectal anastomoses during pelvic exenteration for gynaecological malignancy: British Journal of Surgery. 95:770~773 (4.304)
2008 SCI Interferon regulatory factor-1 (IRF-1) regulates VEGF-induced angiogenesis in HUVECs: Biochimica et Biophysica Acta - Molecular Cell Research. 1783:1654~1662 (4.374)
2008 SCI Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC-22: FEBS Letters. 582:1210~1218 (3.263)
2008 SCI The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization: Gynecologic Oncology. 108:549~554 (2.614)
2008 SCI Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma.: International Journal of Gynecological Cancer(상위20#이내 학술지 아님). Online:Published (1.425)
2008 SCI Trends in cervical cancer mortality in Korea 1993-2002: Corrected mortality using national death certification data: International Journal of Cancer. 122:393~397 (4.555)
2008 SCI FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer: Cancer Genetics and Cytogenetics. 180:1~5 (1.559)
2007 SCI Port-site and liver metastases after laparoscopic pelvic and para-aortic lymph node dissection for surgical staging of locally advanced cervical cancer cancer: International Journal of Gynecological Cancer. 18:176~180 (1.425)
2007 기타 The Effect of Tibolone on Bone Density in Women with Early Menopause Resulting from Cancer Treatment: Journal of the Korean society of osteoporosis. 5:72~77 (0)
2007 SCI The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival: Journal of Surgical Oncology. 96:560~568 (2.384)
2007 SCI Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population.: Cancer. 110:2716~2725 (4.632)
2007 SCI Lymphoepithelioma-like carcinoma of the ovary: a case report and review of the literature.: Arch Pathol Lab Med.. Online:Published ()
2007 SCI The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy: International Journal of Gynecologic Cancer. 17:872~878 (1.469)
2007 SCI Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer.: Gynecol Oncol.. Online:Published (2.319)
2007 SCI Primary Ewing's sarcoma-primitive neuroectodermal tumor of the uterus: A case report and literature review: Gynecologic Oncology. 106:427~432 (2.614)
2007 SCI Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma: Gynecologic Oncology(상위20#이내 학술지 아님). 105:662~666 (2.319)
2007 SCI Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer: International Journal of Gynecological Cancer. 17:492~496 (1.428)
2007 SCI Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical: cancer science. 98:329~333 (3.869)
2007 SCI Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical: Cancer Science. 98:329~333 (3.869)
2007 SCI The C19007T Polymorphism of ERCC1 and Its Correlation with the Risk of Epithelial Ovarian and Endometrial Cancer in Korean Women. A Case Control Study.: Gynecologic and obstetric investigation. 64:84~88 (0.874)
2007 SCI Interleukin-1 beta-511 polymorphism and risk of cervical cancer: Journal of Korean Medical Science. 22:110~113 (0.824)
2006 SCI The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns: Gynecologic Oncology. 103:977~984 (2.251)
2006 SCI MRI for pretreatment lymph node staging in uterine cervical cancer: American Journal of Roentgenology. 187:538~543 (2.209)
2006 SCI Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: From diagnosis to prognosis: Gynecologic Oncology. 103:165~170 (2.251)
2006 SCI RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma: International Journal of Cancer. 119:1316~1321 (4.7)
2006 SCI Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer: Experimental and Molecular Medicine. 38:320~324 (2.296)
2006 SCI Comparison of DNA gypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma: International journal of cancer. 118:2168~2171 (4.7)
2006 SCI CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.: International Journal of Radiation Oncology Biology Physics. 64(1):197~204 (4.556)
2006 SCI Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer: Journal of Cancer Research and Clinical Oncology. 132:302~308 (2.503)
2006 SCI Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.: International journal of cancer.. 118:2168~2171 (4.7)
2005 SCI Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: A prospective surgicopathologic correlation study: European Journal of Cancer. 41:2086~2092 (3.302)
2005 SCI Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: A prospective surgicopathologic correlation study: European Journal of Cancer. 41:2086~2092 (3.302)
2005 SCI Pretreatment laparoscopic surgical staging in locally advanced cervical cancer : preliminary results in Korea: Gynecologic Oncology. 97(2):468~475 (2.083)
2005 SCI Incidental ovarian(18)F-FDG accumulation on PET : correlation with the menstrual cycle: European Journal of Nuclear Medicine and Molecular Imaging. 32:757~763 (3.94)
2005 SCI Computed Tomography findings of ovarian metastases from colon cancer: comparison with primary malignant ovarian tumors: Journal of computer assisted tomography. 29:69~73 (1.357)
2005 SCI Pretreatment laparoscopic surgical staging in locally advanced cervical cancer : preliminary results in Korea: Gynecologic Oncology. 97:468~475 (2.341)
2004 SCI p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer: Gynecol Oncol. 93:499~505 (2.341)
2004 SCI Validation of the Korean version of the EORTC QLQ-C30: Qual Life Res. 13:863~868 (1.5)
2002 SCI Interleukin-10 promoter polymorphism and cervical cancer risk in Korean women: CANCER LETT. 184:57~63 (1.517)
1998 SCI Loss of heterozygosity on chromosome 22q and 17p correlated with aggresiveness of meningioma: Neurooncology. 40:101~106 ()
1997 SCI Device for occlusion of rectovaginal fistula: Clinical trials: Radiology. 203:65~69 (5.377)
1996 SCI Beta core fragment (*-core/UGF/UGP), a tumor marker: seven year report: Gynecologic oncology. 60:264~270 (2.251)
1996 SCI Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy: Gynecologic oncology. 63:105~113 (2.251)
1995 SCI p53 mutation in epithelial carcinoma and borderline ovarian tumor.: Cancer genetics and cytogenetics. 85:43~50 (1.64)
1995 SCI Phase I/II Study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage IIb bulky cervical carcinomai: Cancer. 76:815~823 (4.8)
1995 SCI Expression of CD44 adhesion molecule in primary and metastatic gynecological malignancies and their cell lines.: International journal of gynecological cancer. 5:193~199 (1.427)
1995 SCI Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas.: Cancer genetics and cytogenetics. 79:74~78 (1.64)
1995 SCI Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis: Anticancer research. 15:2777~2780 (1.604)
1994 SCI p53 gene mutation is rare in human cervical carcinomas with postitive HPV sequences: International journal of gynecological cancer. 4:371~378 (1.427)
1994 SCI Stage IIb cervical carcinoma:MR evaluation of effect of intraarterial chemotherapy.: Radiology. 192:61~66 (5.377)
1993 SCI The deactivation of HCG by nicking and dissociation: The Journal of clinical endocrinology and metabolism. 76:704~710 (6.02)
타병원 동일과 LIST
순천향대학교 서울병원
자궁암,부인암,복강경수술,로봇수술,난소종양수술
서울대학교병원
임신,산모질환,임신중독증,산전유전진단,태아치료
강동경희대학교병원
요실금,골반장기탈출증,부인과양성종양,갱년기
호산여성병원
부인암,자궁경부암,자궁내막암,난소암
강동경희대학교병원
부인과복강경수술,부인암,자궁경부암,자궁내막암
가톨릭대학교 서울성모병원
자궁근종,자궁내막증,로봇수술,복강경수술,폐경클리닉
신촌세브란스병원
부인암,부인과내시경수술,부인과로봇수술
삼성서울병원
자궁내막암,난소암,자궁경부암,로봇수술,복강경수술
이대서울병원
부인암,자궁경부암,난소암,자궁내막암,종양,근종
가톨릭대학교 성빈센트병원
부인암,자궁근종,로봇수술,부인암복강경수술
한림대학교 강남성심병원
부인과종양학,복강경수술,로봇수술,일반부인과학
한림대학교 성심병원
자궁경부암,자궁내막암,난소암,외음부암,부인암
서울대학교병원
자궁암,난소암,골반경수술,여성요실금,자궁근종
양산부산대학교병원
자궁경부암,난소암,자궁내막암,부인암
아주대학교병원
부인암,복강경수술,자궁근종,난소종양
신촌세브란스병원
생식내분비,불임,자궁내막증,자궁근종,폐경
서울아산병원
난소종양,골반장기탈출증,로봇수술,자궁경수술
아주대학교병원
부인암,복강경수술,자궁근종,난소종양,요실금
서울대학교병원
난소암,난소종양,자궁체부암,자궁경부암
이대서울병원
부인종양,자궁암,난소암,내막암,로봇수술,단일공수술
서울아산병원
태아심장정밀진단,태아치료,쌍태아간수혈증후군
가톨릭대학교 서울성모병원
자궁근종,자궁내막증,로봇수술
가톨릭대학교 서울성모병원
자궁암,난소암,난소낭종,복강경 수술,로봇수술
가톨릭대학교 서울성모병원
유전성난소암,자궁내막암,자궁경부암
가톨릭대학교 서울성모병원
자궁경부암,난소암,자궁내막암,HPV클리닉
고려대학교 구로병원
자궁내막증,폐경,골다공증,복강경수술
강북삼성병원
요실금,자궁탈출증,양수검사,자연출산,태교클리닉
강동경희대학교병원
산과,산전관리,태아정밀초음파,고위험임신
건국대학교병원
산전유전진단,일반산부인과,성클리닉
강남세브란스병원
자궁내막증,다낭성난소증후군,자궁근종,난소종양
중앙대학교병원
고위험임신,선천성기형,태아치료,태아둔위교정술
중앙대학교병원
자궁경부암,난소암,자궁내막암,로봇수술,골반경수술
강남세브란스병원
부인종양학,난소종양,자궁종양,복강경수술
순천향대학교 부천병원
모성태아의학,고위험임신,다태임신
보라매서울대학교병원
부인과종양,자궁질탈출증,골반재건클리닉
보라매서울대학교병원
일반부인과,자궁근종,난소낭종,자궁경부암결과이상
서울아산병원
자궁내막암,난소암,자궁경부암,복강경수술,로봇수술
서울아산병원
자궁내막증,불임,자궁근종,월경이상,자궁출혈,폐경
서울아산병원
자궁경부암,난소암,부인종양,복강경수술,국제진료센터
|
|